CD40LG and tick-borne infectious disease: Future advancements in serological point-of-care (POC) tests for E. canis detection could benefit from innovative ELISAs targeting both IgM and IgG using the TRP36 protein, thus improving canine health management and public health strategies against tick-borne diseases.